|
Apr 12
|
New AI Bot Predicts These 7 Stocks Will Mint Millionaires
|
|
Apr 8
|
Simulations Plus (SLP) DILIsym Software Licenses Renewed by FDA
|
|
Apr 6
|
Earnings Update: Simulations Plus, Inc. Beat Earnings And Now Analysts Have New Forecasts For This Year
|
|
Apr 5
|
Simulations Plus Second Quarter 2024 Earnings: Beats Expectations
|
|
Apr 4
|
Simulations Plus, Inc. (NASDAQ:SLP) Q2 2024 Earnings Call Transcript
|
|
Apr 4
|
U.S. FDA Renews DILIsym® Software Licenses for 7th Year
|
|
Apr 4
|
Simulations Plus (SLP) Q2 Earnings & Revenues Beat Estimates
|
|
Apr 4
|
Q2 2024 Simulations Plus Inc Earnings Call
|
|
Apr 3
|
Simulations Plus Inc (SLP) Aligns with EPS Projections and Maintains Full-Year Guidance
|
|
Apr 3
|
Simulations Plus (SLP) Q2 Earnings and Revenues Surpass Estimates
|
|
Apr 3
|
Simulations Plus Reports Second Quarter Fiscal 2024 Financial Results
|
|
Apr 2
|
Simulations Plus (SLP) to Report Q2 Earnings: What's in Store?
|
|
Mar 20
|
Simulations Plus Announces Second Quarter Fiscal Year 2024 Earnings and Conference Call Date
|
|
Mar 14
|
Investing in Simulations Plus (NASDAQ:SLP) five years ago would have delivered you a 110% gain
|
|
Mar 13
|
Simulations Plus to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum
|
|
Mar 5
|
Director and 10% Owner Walter Woltosz Sells 20,000 Shares of Simulations Plus Inc (SLP)
|
|
Mar 5
|
Simulations Plus and the University of Bath Awarded New FDA Grant
|
|
Jan 11
|
Bears are Losing Control Over Simulations Plus (SLP), Here's Why It's a 'Buy' Now
|
|
Jan 9
|
Simulations Plus Embarks on Collaboration with Northeastern University and The TIM Company Through New FDA Grant
|
|
Dec 29
|
Simulations Plus (SLP) to Report Q1 Earnings: What's in Store?
|